CD8+and CD20+Lymphocytes Cooperate To Control Acute Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys: Modulation by Major Histocompatibility Complex Genotype
Open Access
- 15 December 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (23) , 14887-14898
- https://doi.org/10.1128/jvi.79.23.14887-14898.2005
Abstract
We have previously described two isogenic molecularly cloned simian immunodeficiency virus/human immunodeficiency virus chimeric viruses (SHIVs) that differ from one another by 9 amino acids and direct distinct clinical outcomes in inoculated rhesus monkeys. SHIVDH12R-Clone 7, like other highly pathogenic CXCR4-tropic SHIVs, induces rapid and complete depletions of CD4+T lymphocytes and immunodeficiency in infected animals. In contrast, macaques inoculated with SHIVDH12R-Clone 8experience only partial and transient losses of CD4+T cells, show prompt control of their viremia, and remain healthy for periods of time extending for up to 4 years. The contributions of CD8+and CD20+lymphocytes in suppressing the replication of the attenuated SHIVDH12R-Clone 8and maintaining a prolonged asymptomatic clinical course was assessed by treating animals with monoclonal antibodies that deplete each lymphocyte subset at the time of virus inoculation. The absence of either CD8+or CD20+cells during the SHIVDH12R-Clone 8acute infection resulted in the rapid, complete, and irreversible loss of CD4+T cells; sustained high levels of postpeak plasma viremia; and symptomatic disease in Mamu-A*01-negative Indian rhesus monkeys. In Mamu-A*01-positive animals, however, the aggressive, highly pathogenic phenotype was observed only in macaques depleted of CD8+cells; SHIVDH12R-Clone 8was effectively controlled in Mamu-A*01-positive monkeys in the absence of B lymphocytes. Taken together, these results indicate that both CD8+and CD20+B cells contribute to the control of primate lentiviral infection in Mamu-A*01-negative macaques. Furthermore, the major histocompatibility complex genotype of an infected animal, as exemplified by the Mamu-A*01 allele in this study, has the additional capacity to shift the balance of the composite immune response.Keywords
This publication has 46 references indexed in Scilit:
- Effect of CD8 + Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus MacaquesJournal of Virology, 2005
- Vaccine-Elicited Memory Cytotoxic T Lymphocytes Contribute toMamu-A*01-Associated Control of Simian/Human Immunodeficiency Virus 89.6P Replication in Rhesus MonkeysJournal of Virology, 2005
- Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cellsNature, 2005
- Induction of Disease by a Molecularly Cloned Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimera Is MultigenicJournal of Virology, 2004
- Major Histocompatibility Complex Class I Alleles Associated with Slow Simian Immunodeficiency Virus Disease Progression Bind Epitopes Recognized by Dominant Acute-Phase Cytotoxic-T-Lymphocyte ResponsesJournal of Virology, 2003
- Importance of B-Cell Responses for Immunological Control of Variant Strains of Simian Immunodeficiency VirusJournal of Virology, 2003
- Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus InfectionJournal of Virology, 2002
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- HIV-Specific Cellular and Humoral Immune Responses in Primary HIV InfectionAIDS Research and Human Retroviruses, 1996